Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide

Fizazi, K; Shore, N; Tammela, TL; Ulys, A; Vjaters, E; Polyakov, S; Jievaltas, M; Luz, M; Alekseev, B; Kuss, I; Le Berre, MA; Petrenciuc, O; Snapir, A; Sarapohja, T; Smith, MR

NEW ENGLAND JOURNAL OF MEDICINE, 2020; 383 (11): 1040

Abstract

BackgroundDarolutamide is a structurally distinct androgen-receptor inhibitor that is approved for the treatment of nonmetastatic, castration-resistan......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索